Skip to content

Immediate analgesia effect of radial extracorporeal shock wave in primary dysmenorrhea based on resting state fMRI: a randomized controlled trial

Immediate analgesia effect of radial extracorporeal shock wave in primary dysmenorrhea based on resting state fMRI: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020678
Enrollment
Unknown
Registered
2019-01-13
Start date
2019-01-30
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea

Interventions

Group 1:Non-steroidal anti-inflammatory drugs
Group 2:radial extracorporeal shock wave

Sponsors

Central Hospital of Shanghai Xuhui
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: (1) periodic abdominal pain before menstruation or during menstruation, accompanied by lumbar acid or other discomfort; (2) childless young women aged 18-30 years; (3) no pelvic organic diseases, excluding secondary dysmenorrhea caused by endometriosis, adenomyosis, submucosal fibroids, etc.; (4) menstrual cycle: 28±7 days; (5) pain in menstrual cycle for 6 months or more; (6) VAS=40mm; (7) no oral contraceptives or drugs acting on the central nervous system were taken within 6 months before treatment, and no painkillers or antidepressants were taken within 24 hours; (8) use the right limb; (9) not received extracorporeal shock wave therapy before; (10) voluntarily participate in the experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) secondary dysmenorrhea caused by pelvic organic diseases such as endometriosis, adenomyosis and submucosal fibroids; (2) women who have a birth plan in the next six months or in pregnant or has given birth; (3) irregular menstrual cycles; (4) be allergic to the coupling agent; (5) have histological changes in the skin or muscle of the treatment site; (6) patients with severe mental illness; (7) have serious diseases such as heart, brain, liver, kidney, and hematopoietic system; (8) contraindications to magnetic resonance imaging(claustrophobia, metal implants or cardiac pacemakers in the body).

Design outcomes

Primary

MeasureTime frame
short-form mcgill pain questionnaire (SF-MPQ);The COX menstrual symptom scale, CMSS;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale, SAS;Self-Rating Depression Scale, SDS;amplitude of low-frequency fluctuation (ALFF);

Countries

China

Contacts

Public ContactJian Yang

Central Hospital of Shanghai Xuhui District

dr.yj168@163.com+86 13361801366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026